RE-BVS – Piemonte Repository

Sfoglia per AUTORE
VALENTINO P
Collezione AOU Città della Salute di Torino

Items : 7

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry. in Journal of neurology / J Neurol. 2024 Mar;271(3):1150-1159. doi: 10.1007/s00415-023-12137-8. Epub 2023 Dec 22.

2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferraro D; Gasperini C; Salemi G; Bergamaschi R; Lus G; Inglese M; Romano S; Bellantonio P; Di Monte E; Maniscalco GT; Conte A; Lugaresi A; Trojano M; Filippi M; Amato MP; Nica M; Ragonese P; Ruggieri S; Carotenuto A; Tortorella C; Fenu G; Onofrj M; Portaccio E; Chisari CG; Rocca MA; Ardito B; Banfi P; Nasuelli D; Paolicelli D; et alii...

Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA. in Hepatology (Baltimore, Md.) / Hepatology. 2024 Jun 1;79(6):1279-1292. doi: 10.1097/HEP.0000000000000727. Epub 2023 Dec 25.

2024
AOU Città della Salute di Torino

Wiecek S; Desai DM; Önal Z; Eshun J; Melere M; Carvalho E; Alam S; Waisbourd-Zinman O; Arikan C; Lertudomphonwanit C; Hajinicolaou C; Cavalieri ML; Lee WS; Kim KM; Oh SH; Sanchez MC; Wang JS; She H; Li LT; Banales JM; Mujawar Q; Jimenez-Rivera C; Sandahl TD; Kelly DA; Busoms CM; Karnsakul W; Tamara ML; Nastasio S; Fawaz R; et alii...

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. in Hepatology (Baltimore, Md.) / Hepatology. 2023 Feb 1;77(2):512-529. doi: 10.1002/hep.32761. Epub 2022 Oct 13.

2023
AOU Città della Salute di Torino

Jimenez-Rivera C; Sandahl TD; Beretta M; Garcia J; Schwarz K; Zizzo AN; Tamara ML; Wolters VM; Nebbia G; Pinto RB; Wiecek S; Rogalidou M; Dezs?fi A; Desai DM; Eshun J; Valentino PL; Önal Z; Calvo PL; Bulut P; Quiros-Tejeira RE; Indolfi G; Ferreira CT; Carvalho E; Kelly DA; Alam S; Bernabeu JQ; Lin HC; Arikan C; Mozer-Glassberg Y; et alii...

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study. in Neurology and therapy / Neurol Ther. 2023 Aug;12(4):1375-1383. doi: 10.1007/s40120-023-00481-w. Epub 2023 May 11.

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Capobianco MA; Pautasso M; Bertolotto A; Valentino P; Martire S; Sala A; Sperli F; Malentacchi M; Malucchi S; Bruschi N;

Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Apr;60:103740. doi: 10.1016/j.msard.2022.103740. Epub 2022 Mar 12.

2022
AOU Città della Salute di Torino

De Martino A; Cavalla P; Valentino P; Marfia GA; Lavorgna L; Miele G; Maida E; Abbadessa G; Bonavita S;

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Aug 2;18(15):8163. doi: 10.3390/ijerph18158163.

2021
AOU Città della Salute di Torino

Abbadessa G; Miele G; Cavalla P; Valentino P; Marfia GA; Signoriello E; Landi D; Bosa C; Vercellino M; De Martino A; Missione R; Sparaco M; Lavorgna L; Lus G; Bonavita S;

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...